buspirone has been researched along with Breast Neoplasms in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the responses of breast cancer survivors with or without CRFS to the buspirone challenge test (an index of central serotonin sensitivity)." | 5.14 | Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome. ( Alexander, S; Andrews, P; Bano, G; Nussey, S; Stone, P; White, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, S | 1 |
| Stone, P | 1 |
| White, S | 1 |
| Andrews, P | 1 |
| Nussey, S | 1 |
| Bano, G | 1 |
1 trial available for buspirone and Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome.
Topics: Area Under Curve; Breast Neoplasms; Buspirone; Double-Blind Method; Fatigue; Female; Humans; Hydroco | 2010 |